We are live on ! Find out more
ENZY

Enzymotec Ltd
ENZY

Delisted

ENZY was delisted on the 10th of January, 2018.

Back to rankings

23 hedge funds and large institutions have $109M invested in Enzymotec Ltd in 2013 Q4 according to their latest regulatory filings, with 22 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

4,535% more capital invested

Capital invested by funds: $2.35M → $109M (+$107M)

2,100% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 1

1,050% more funds holding

Funds holding: 2 → 23 (+21)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
23
Holders Change
+21
Holders Change %
+1,050%
% of All Funds
0.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PC
Paulson & Co
New York
+$41.2M
2
VAM
Visium Asset Management
New York
+$16.4M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$12.3M
4
GGHC
Gilder Gagnon Howe & Co
New York
+$5.19M
5
BA
BlackRock Advisors
Delaware
+$4.97M

Top Sellers

Rank Fund Capital Flow
1
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$828K
2
DCM
Driehaus Capital Management
Illinois
-$188K

ENZY Hedge Fund Activity: Q4 2013 in Review

23 of the 3,459 institutional investors tracked by Wall St. Rank reported a position in Enzymotec Ltd (ENZY) for Q4 2013, worth a combined $109M — up 4,535% from $2.35M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new ENZY positions and 1 closed out — a net gain of 21 holders — while 0 added to existing stakes and 1 trimmed.

The largest buyer was Paulson & Co, opening a new position worth an estimated $41.2M. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $828K sold.

  • 23 institutional investors held Enzymotec Ltd (ENZY) as of Q4 2013, up from 2 in Q3 2013.
  • Funds reported $109M of Enzymotec Ltd stock for Q4 2013, up 4,535% quarter-over-quarter.
  • 22 funds opened new Enzymotec Ltd positions in Q4 2013 and 1 closed out, a net change of +21 holders.
  • The largest Enzymotec Ltd buyer in Q4 2013 was Paulson & Co, an estimated $41.2M added.
  • The largest Enzymotec Ltd seller in Q4 2013 was Alyeska Investment Group, an estimated $828K sold.

Based on aggregated 13F filings for Q4 2013.